About Osteoboost
Osteoboost is a company founded in 2018 by Nikhil Viswanathan, Daniel Burnett, Michael Jaasma, and Shane Mangrum. Osteoboost has raised $8 million across 5 funding rounds from investors including HHS, Good Growth Capital and Terumo Medical Corporation. Osteoboost operates in a competitive market with competitors including Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
- Founders Nikhil Viswanathan, Daniel Burnett, Michael Jaasma, Shane Mangrum
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
HHS
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Osteoboost
Osteoboost has successfully raised a total of $8M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Osteoboost
Osteoboost has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Good Growth Capital and Terumo Medical Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare startups are funded by Esplanade Ventures venture capital.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early-stage investments are made in life sciences and technologies.
|
Locked | Locked | Locked |
Investor details for Osteoboost
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Osteoboost
Investment portfolio details for Osteoboost
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Osteoboost
Detailed financials for Osteoboost
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Osteoboost Comparisons
Peer comparison for Osteoboost
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Osteoboost
Osteoboost operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trice Medical, Edge Surgical, OrthoScan, Onicorp and Bone Index Finland, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Needle-based visualization devices for orthopedic diagnostics are developed.
|
|
| Locked | Locked | Locked |
Digital depth gauges for orthopedic bone measurements are supplied.
|
|
| Locked | Locked | Locked |
Mini C-arms for orthopedic imaging are developed by OrthoScan.
|
|
| Locked | Locked | Locked |
MRI systems for extremity imaging are developed and marketed.
|
|
| Locked | Locked | Locked |
Ultrasound-based POC device for osteoporosis screening is developed.
|
|
| Locked | Locked | Locked |
Robotic surgical systems for orthopedic treatments are provided.
|
Detailed competitors of Osteoboost
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Osteoboost
Complete news archive for Osteoboost
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Osteoboost
Osteoboost was founded in 2018.
Daniel Burnett is the current CEO of Osteoboost. They have also founded this company.
Osteoboost is a funded company, having raised a total of $8M across 5 funding rounds to date.
Osteoboost was founded in 2018 as a medical device company focused on non-pharmacological treatments for osteopenia in postmenopausal women. A wearable device is utilized to apply precise mechanical vibrations to the lumbar spine and hips, aiming to mitigate declines in bone strength and density. Operations center on developing and providing this patented therapy within the health technology sector.
Osteoboost's top competitors include Edge Surgical, Trice Medical and Echolight Medical.
Osteoboost has 13 investors. Key investors include HHS, Good Growth Capital, Terumo Medical Corporation, Esplanade Ventures, and Berkeley Catalyst Fund.